핵산증폭시험을 이용한 혈장분획물질에서 HCV RNA 검출 = A Nucleic Acid Amplification Tests for Reliable HCV RNA Detection Method for Plasma-Derived Products

다국어 초록 (Multilingual Abstract)

HCV is transmitted via various plasma derived products. Current methods to detect hepatitis C virus (HCV) are based on its antibody detection in the donated blood and plasma. Viral contamination can potentially escape such detection during the window period of infection, when no antibody is present or the level of antibody is too low to detect. It is trying to application of nucleic acid amplification tests (NAT) for the direct detection of HCV. The objective of this study was to develop a reliable NAT for the HCV RNA detection from plasma-derived products. The most useful primers was selected for NAT among 5 sets of primers. We have also found that QIAamp viral RNA isolation kit was the most efficient for HCV RNA isolation. The highest sensitivity and specificity was appeared in $48^{\circ}C$ annealing temperature and 30 pmol of primers. With a spiking of HCV to albumin, immunoglobulins and coagulation factors, NAT can detect up to 100 IU/ml. Meanwhile, COBAS amplicor HCV 2.0 afforded a lower sensitivity in high concentrated intramuscular immunoglobulins to below 500 IU/ml. Our results suggested that NAT appears to be a highly sensitive and specific method for HCV RNA detection in plasma-derived products.

참고문헌 (Reference)

1 Chandra, S., "Virus reduction in the preparation of intravenous immune globullin: in vitro experiments" 39 : 249-257, 1999

2 Sayah, N., "Simultaneous amplification and detection of specific Hepatitis B virus and Hepatitis C virus genomic sequences in serum samples" 42 : 212-216, 1994

3 Hsiang, J.L., "Polymerase chain reaction assay for Hepatitis C virus RNA using a single tube for reverse ranscription and serial rounds of amplification with nested primer pairs" 38 : 220-225, 1992

4 Christopher, J., "Outbreak of acute hepatitis C following the use of anti-hepatitis C virus-screened intravenous immunoglobulin therapy" 110 : 1120-1126, 1996

5 Echevarria, J.M., "Laboratory diagnosis and molecular epidemiology of an outbreak of hepatitis C virus infection among recipients of human intravenous immunoglobulin in Spain" 36 : 725-730, 1996

6 Choo, Q.L., "Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome" 244 : 359-362, 1989

7 Wilson, I.G, "Inhibition and facilitation of nucleic acid amplification" 63 : 3741-3751, 1997

8 Bukh, J., "Importance of primer selection for the detection of hepatitis C virus RNA with the polymerase chain reaction assay" 89 : 187-191, 1992

9 Waleed, A.A., "Identification and characterization of immunoglobulin G in blood as a major inhibitor of diagnostic PCR" 38 : 345-350, 2000

10 Petrik, J., "High throughput PCR detection of HCV based on semiautomated multisample RNA capture" 64 : 147-159, 1997

11 Houghton, M., "Hepatis C virus (HCV): A relative of the pestiviruses and flaviviruses in: Viral Hepatitis and Liver Disease" The Williams & Wilkins Co., Baltimore 328-333, 1991

12 Lee, D.S., "Distribution of HCV genotypes among blood donors, patients with chronic liver disease, hepatocellular carcinoma, and patients on maintenance hemodialysis in Korea" 49 : 55-60, 1996

13 Heermann, K.H., "Capture and RT-PCR of hepatitis C virus RNA with safety primers" 59 : 33-43, 1996

14 James, L.G, "Blood screening by nucleic acid amplification technology : Current issues, future challenges" 5 : 11-22, 2000

15 Widell, A, "At least three hepatitis C virus strains implicated in Swedish and Danish patients with intravenous immunoglobulin-associated hepatitis C" 37 : 313-320, 1997

16 Fanson, B.G., "A comparison between the phenol-chloroform method of RNA extraction and the QIAamp viral RNA kit in the extraction of hepatitis C and GB virus-C/hepatitis G viral RNA from serum" 89 : 23-27, 2000